| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8965575 | Clinical Biochemistry | 2018 | 36 Pages |
Abstract
Our results provide evidence that miR-331 levels might provide valuable information regarding the differential diagnosis of benign and malignant breast tumors but present no prognostic value for breast cancer.
Keywords
FDAFibrocystic breast diseaseASCOESMOTNMHER2NCCNIDCILCmiRNAsDFSROCDCISFBDAUCcDNAComplementary DNADuctal adenocarcinomastandard deviationRelative quantificationdisease-free survivaloverall survivalBiomarkermicroRNAsWorld Health Organization.Food and Drug AdministrationBreast cancerNational Comprehensive Cancer NetworkFibroadenomaarea under the curvereceiver operating characteristicsquartileDuctal carcinoma in situInvasive lobular carcinomaInvasive ductal carcinomaCollege of American PathologistsCaPWHOEstrogen receptorHuman epidermal growth factor receptor 2Progesterone receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Emmanuel I. Papadopoulos, Georgia Papachristopoulou, Alexandros Ardavanis, Andreas Scorilas,